Drug:
Reaction: ECZEMA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26547683 |
US |
1 | |
Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 102 | 26547733 |
US |
1 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 103 | 26547792 |
US |
36 | 2 |
Eczema, Rash, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 104 | 26547834 |
US |
62 | 2 |
Eczema, Product dose omission in error, Product use issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 105 | 26547879 |
US |
23 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 106 | 26547973 |
US |
9 | 1 |
Dermatitis atopic, Asthma, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 107 | 26548192 |
US |
2 | |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 108 | 26548198 |
US |
45 | 2 |
Eczema, Gastrooesophageal reflux disease, Product dose omission issue, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 109 | 26548200 |
US |
34 | 1 |
Eczema, Pruritus, Swelling, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 110 | 26548260 |
US |
2 | |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 111 | 26548283 |
US |
||
Eczema, |
||||
DUPILUMAB, |
||||
| 112 | 26548289 |
US |
30 | 1 |
Eczema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 113 | 26548422 |
US |
4 | 1 |
Sleep disorder due to a general medical condition, Skin haemorrhage, Skin fissures, Pain of skin, Eczema, Injection site pain, |
||||
DUPILUMAB, |
||||
| 114 | 26548447 |
US |
26 | 2 |
Eczema, Burning sensation, Pruritus, |
||||
DUPILUMAB, |
||||
| 115 | 26548448 |
US |
19 | 2 |
Off label use, Eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 116 | 26548675 |
US |
24 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 117 | 26548689 |
US |
1 | |
Psoriasis, Eczema, Pain of skin, Gait disturbance, Therapeutic product effect decreased, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 118 | 26548755 |
US |
1 | |
Eczema, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 119 | 26548788 |
US |
1 | |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 120 | 26542518 |
US |
63 | 2 |
Pneumonia, Foot fracture, Hip arthroplasty, Tooth fracture, Ankle fracture, Bronchitis, Pharyngitis streptococcal, Sinusitis, Skin ulcer, Eczema, Conjunctivitis, Ear disorder, Stress, Sensitive skin, |
||||
ETANERCEPT, ETANERCEPT, PREDNISONE, MELOXICAM, |
||||
| 121 | 26543572 |
US |
27 | 1 |
Eczema, Injection site pain, |
||||
TRALOKINUMAB-LDRM, |
||||
| 122 | 26544248 |
US |
2 | |
Eczema, Urticaria, Rash, |
||||
TIRZEPATIDE, |
||||
| 123 | 26544500 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 124 | 26545247 |
|||
Eczema, Diarrhoea, |
||||
ACYCLOVIR, PANTOPRAZOLE, |
||||
| 125 | 26546014 |
US |
23 | 2 |
Product use in unapproved indication, Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Eczema, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 126 | 26536307 |
CA |
28 | |
Eczema, Acne, Psoriasis, Drug ineffective, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 127 | 26537593 |
US |
52 | 2 |
Eczema, Mood altered, Insomnia, Loss of personal independence in daily activities, |
||||
TRALOKINUMAB-LDRM, |
||||
| 128 | 26537724 |
US |
3 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 129 | 26537726 |
US |
1 | 2 |
Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 130 | 26537795 |
EU |
19 | 1 |
Pyoderma gangrenosum, Eczema, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 131 | 26537802 |
US |
1 | |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 132 | 26538064 |
US |
3 | 1 |
Eczema, Dermatitis, Dry skin, Pruritus, Scratch, Skin haemorrhage, Wound, |
||||
DUPILUMAB, |
||||
| 133 | 26538067 |
US |
21 | 2 |
Eczema, Injection site pain, |
||||
DUPILUMAB, |
||||
| 134 | 26538211 |
US |
43 | 2 |
Eczema, Rash, Sleep disorder due to a general medical condition, Discomfort, Product dose omission issue, |
||||
DUPILUMAB, AMMONIUM LACTATE, BUPROPION, CYCLOBENZAPRINE, DICLOFENAC, DICLOFENAC SODIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FLUOROMETHOLONE, GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, NALTREXONE, |
||||
| 135 | 26538215 |
US |
50 | 2 |
Skin lesion, Eczema, Herpes zoster, Skin exfoliation, |
||||
DUPILUMAB, UPADACITINIB, SECUKINUMAB, IXEKIZUMAB, CYCLOSPORINE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, PROGESTERONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PRASTERONE, FISH OIL, ACETAMINOPHEN, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, METHOTREXATE SODIUM, ADALIMUMAB, MELOXICAM, PAROXETINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, FAMOTIDINE, FLUTICASONE PROPIONATE, IVERMECTIN, CLOCORTOLONE PIVALATE, |
||||
| 136 | 26538426 |
US |
25 | 2 |
Tonsillectomy, Eczema, Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 137 | 26538783 |
US |
31 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 138 | 26538793 |
US |
50 | 2 |
Eczema, Product dose omission issue, Pruritus, Skin irritation, |
||||
DUPILUMAB, |
||||
| 139 | 26539170 |
EU |
1 | 1 |
Polypectomy, Dermatosis, Speech disorder developmental, Dyslalia, Nervous system disorder, Fatigue, Immunisation reaction, Pyrexia, Tonsillectomy, Eczema, Infection susceptibility increased, Influenza like illness, |
||||
| 140 | 26539854 |
US |
1 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 141 | 26539869 |
US |
67 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 142 | 26539931 |
US |
40 | 2 |
Eczema, Skin fissures, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 143 | 26539934 |
US |
2 | |
Eczema, Skin discolouration, Pain, Rash, Skin exfoliation, Dry skin, Product dose omission issue, |
||||
DUPILUMAB, ALBUTEROL SULFATE, AMIODARONE HYDROCHLORIDE, AMLODIPINE BESYLATE, INDAPAMIDE, MELOXICAM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MONTELUKAST SODIUM, MONTELUKAST, ERGOCALCIFEROL, |
||||
| 144 | 26540816 |
US |
26 | 1 |
Eczema, Product dose omission issue, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 145 | 26540822 |
US |
2 | |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 146 | 26540831 |
US |
1 | |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 147 | 26540939 |
US |
3 | 2 |
Eczema, Dry skin, |
||||
DUPILUMAB, |
||||
| 148 | 26540942 |
US |
4 | 1 |
Eczema, Erythema, Dry skin, Erythema of eyelid, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 149 | 26540950 |
US |
22 | 2 |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 150 | 26540951 |
US |
23 | 2 |
Eczema, Dry skin, Incorrect dose administered by product, Condition aggravated, Accidental exposure to product, Exposure via skin contact, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 151 | 26541012 |
US |
2 | |
Eczema, Erythema, Skin irritation, Pruritus, Rash erythematous, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 152 | 26541017 |
US |
2 | 1 |
Decreased appetite, Skin exfoliation, Skin discolouration, Rash, Eczema, Swelling face, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 153 | 26541052 |
US |
74 | 2 |
Eczema, Arthralgia, |
||||
DUPILUMAB, |
||||
| 154 | 26531407 |
GB |
77 | 1 |
Eczema, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, RAMIPRIL, RAMIPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES, SENNA LEAF, SENNA, BUPRENORPHINE, BUPRENORPHINE, EZETIMIBE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TRIMETHOPRIM, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), PREGABALIN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, |
||||
| 155 | 26531585 |
US |
||
Pyrexia, Night sweats, Tachycardia, Dizziness, Lethargy, Nausea, Headache, Eczema, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 156 | 26531983 |
US |
||
Headache, Pruritus, Eczema, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 157 | 26533034 |
US |
30 | 2 |
Eczema, Pyrexia, Insomnia, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 158 | 26533108 |
US |
70 | 2 |
Eczema, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 159 | 26533165 |
US |
1 | |
Eczema, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 160 | 26533277 |
US |
27 | 1 |
Nasal inflammation, Eczema, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 161 | 26533324 |
US |
2 | |
Eczema, Drug ineffective, Rash, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 162 | 26533335 |
US |
53 | 1 |
Eczema, Pruritus, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 163 | 26533367 |
US |
18 | 2 |
Eczema, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 164 | 26533392 |
US |
1 | |
Eczema, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 165 | 26533403 |
US |
4 | 2 |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 166 | 26533406 |
US |
70 | 2 |
Eczema, Pruritus, Erythema, Intentional dose omission, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 167 | 26533414 |
US |
1 | |
Eczema, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 168 | 26533495 |
US |
5 | 2 |
Eczema, Off label use, |
||||
DUPILUMAB, |
||||
| 169 | 26533499 |
US |
9 | 2 |
Anxiety, Stress, Eczema, Rash, Pruritus, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 170 | 26533502 |
US |
33 | 2 |
Increased appetite, Eczema, Injection site pain, Intentional product misuse, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, PREDNISONE, |
||||
| 171 | 26533601 |
US |
34 | 2 |
Insomnia, Activities of daily living decreased, Mood disorder due to a general medical condition, Eczema, Pruritus, Inflammation, Rash erythematous, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 172 | 26534288 |
US |
25 | 2 |
Eczema, Rash erythematous, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 173 | 26534408 |
US |
57 | 1 |
Eczema, Rash, Discomfort, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 174 | 26534792 |
US |
58 | 2 |
Eczema, Bone pain, Sensitive skin, Pruritus, Arthralgia, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, LOSARTAN POTASSIUM, LOSARTAN, MONTELUKAST SODIUM, MONTELUKAST, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, BACLOFEN, EPINEPHRINE, ESOMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, NASAL, SODIUM CHLORIDE, SALINE, |
||||
| 175 | 26534829 |
US |
2 | |
Eczema, Rash macular, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 176 | 26535093 |
US |
20 | 2 |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 177 | 26535110 |
US |
73 | 1 |
Erythema, Discomfort, Eczema, |
||||
DUPILUMAB, |
||||
| 178 | 26535111 |
US |
15 | 1 |
Eczema, Pruritus, Discomfort, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 179 | 26535268 |
EU |
64 | 2 |
Myocarditis, Dermatitis exfoliative generalised, Eczema, Pruritus, Product use in unapproved indication, |
||||
LENALIDOMIDE, |
||||
| 180 | 26535721 |
US |
||
Rash, Eczema, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 181 | 26537771 |
72 | 2 | |
Eczema, Skin exfoliation, Skin haemorrhage, Skin fissures, Skin swelling, Rash, Pain of skin, |
||||
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, AMLODIPINE, ERGOCALCIFEROL, |
||||
| 182 | 26527160 |
US |
||
Hepatotoxicity, Erythema, Eczema, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 183 | 26527815 |
US |
1 | |
Suicidal ideation, Abdominal discomfort, Depression, Eczema, |
||||
DUPILUMAB, |
||||
| 184 | 26528499 |
|||
Eczema, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 185 | 26528549 |
1 | 2 | |
Drug ineffective, Therapy change, Steroid withdrawal syndrome, Skin erosion, Skin weeping, Dry skin, Skin exfoliation, Scab, Pruritus, Crying, Emotional distress, Rash erythematous, Failure to thrive, Eosinophilia, Eczema, Lactation disorder, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 186 | 26529761 |
CA |
22 | |
Lower respiratory tract infection, Eczema, Inappropriate schedule of product administration, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, PREDNISONE, |
||||
| 187 | 26529785 |
SG |
84 | 2 |
Eczema, Drug-induced liver injury, |
||||
| 188 | 26530145 |
US |
||
Application site dryness, Eczema, |
||||
RUXOLITINIB, |
||||
| 189 | 26530993 |
CA |
32 | |
Abdominal pain, Anxiety, Asthma, Blood pressure increased, Eczema, Emphysema, Forced expiratory volume decreased, Heart rate increased, Middle insomnia, Migraine, Nasal congestion, Obstructive airways disorder, Oropharyngeal pain, Productive cough, Psoriasis, Restrictive pulmonary disease, Rhinitis, Sleep disorder, Stress, Tachycardia, Terminal insomnia, Upper-airway cough syndrome, Vomiting, Tooth abscess, Wheezing, Dyspnoea, Ear infection, Nasopharyngitis, Sinusitis, Diarrhoea, Cough, Urticaria, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, QUETIAPINE FUMARATE, QUETIAPINE, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TERBUTALINE SULFATE, IPRATROPIUM BROMIDE, AMLODIPINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, CICLESONIDE, SEMAGLUTIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 190 | 26522892 |
CA |
32 | |
Abdominal pain, Anxiety, Asthma, Bacterial infection, Blood pressure increased, Decreased activity, Dyspnoea, Dyspnoea exertional, Ear infection, Eczema, Emphysema, Eosinophil count abnormal, Feeding disorder, Forced expiratory volume decreased, Full blood count abnormal, Fungal infection, Heart rate increased, Infection, Influenza, Malaise, Middle insomnia, Migraine, Musculoskeletal chest pain, Nasal congestion, Nasal discharge discolouration, Nasopharyngitis, Obstructive airways disorder, Oropharyngeal pain, Pain, Pneumonia, Productive cough, Psoriasis, Rales, Restrictive pulmonary disease, Rhinitis, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Stress, Tachycardia, Terminal insomnia, Tooth abscess, Upper-airway cough syndrome, Urinary tract infection, Vertigo, Vomiting, Wheezing, Cough, Dizziness, Diarrhoea, Urticaria, Drug ineffective, Product administration error, Therapeutic response decreased, Therapeutic product effect decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, MONTELUKAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TERBUTALINE SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, EPINEPHRINE, CICLESONIDE, QUETIAPINE FUMARATE, QUETIAPINE, SEMAGLUTIDE, SEMAGLUTIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 191 | 26523622 |
US |
65 | 2 |
Hidradenitis, Cranial nerve paralysis, Vision blurred, Eczema, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 192 | 26523740 |
CA |
||
Abdominal discomfort, Bronchiectasis, Alcohol poisoning, Arthritis, Burns second degree, COVID-19, Cardiac murmur, Catarrh, Cerebrovascular accident, Colitis ulcerative, Condition aggravated, Confusional state, Deep vein thrombosis, Depression, Dysgeusia, Frequent bowel movements, Gingival pain, Haematochezia, Hypopnoea, Impaired quality of life, Impaired work ability, Inappropriate schedule of product administration, Intentional product use issue, Loss of personal independence in daily activities, Medication error, Migraine, Nightmare, Off label use, Palpitations, Parosmia, Product use in unapproved indication, Pulmonary embolism, Rectal haemorrhage, Rhinitis, Stress, Swollen tongue, Vertigo, Tubulointerstitial nephritis, Weight decreased, Accidental overdose, Systemic lupus erythematosus, Drug ineffective, Somnolence, Eczema, Headache, Fatigue, Pyrexia, Pain, Pain in extremity, Rash, Tinnitus, Steroid dependence, Adverse drug reaction, |
||||
MESALAMINE, MESALAMINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALBENDAZOLE, ALBENDAZOLE, ALBENDAZOLE, BUDESONIDE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DAPAGLIFLOZIN, DAPAGLIFLOZIN, DESOXIMETASONE, DESOXIMETASONE, VEDOLIZUMAB, VEDOLIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FUROSEMIDE, GABAPENTIN, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE, INFLIXIMAB, INFLIXIMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MESALAMINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, WARFARIN, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, |
||||
| 193 | 26524184 |
EU |
2 | |
Paraesthesia, Hypoaesthesia, Eczema, Feeling hot, Somnolence, |
||||
LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, |
||||
| 194 | 26525098 |
52 | 2 | |
Eczema, Dry skin, |
||||
| 195 | 26526153 |
GB |
77 | 1 |
Eczema, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TRIMETHOPRIM, TRIMETHOPRIM, TRIMETHOPRIM, TRIMETHOPRIM, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES, SENNA LEAF, SENNA, BUPRENORPHINE, BUPRENORPHINE, BUPRENORPHINE, BUPRENORPHINE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, EZETIMIBE, EZETIMIBE, EZETIMIBE, EZETIMIBE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, |
||||
| 196 | 26526342 |
US |
||
Eczema, Off label use, |
||||
RUXOLITINIB, |
||||
| 197 | 26521976 |
US |
65 | 1 |
Groin infection, Eczema, Rash, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 198 | 26522082 |
US |
89 | 2 |
Injection site reaction, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 199 | 26522177 |
US |
90 | 2 |
Stress, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 200 | 26522193 |
US |
2 | |
Eczema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28